Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0T7WQ
|
||||
| Former ID |
DIB003496
|
||||
| Drug Name |
Datelliptium chloride
|
||||
| Synonyms |
Datelliptinium; Detalliptinium; SR-95156B
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Breast cancer [ICD9: 174, 175; ICD10:C50] | Terminated | [1] | ||
| Company |
Sanofi
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C23H28ClN3O
|
||||
| Canonical SMILES |
c12c([nH]c3c1cc(cc3)O)c(c1c(c2C)c[n+](cc1)CCN(CC)CC)C.[<br />Cl-]
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | DNA topoisomerase II | Target Info | Modulator | [2] | |
| DNA topoisomerase I | Target Info | Modulator | [2] | ||
| WikiPathways | Integrated Pancreatic Cancer Pathway | ||||
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001278) | ||||
| REF 2 | Toxicity of the antitumoral drug datelliptium in hepatic cells: Use of models in vitro for the prediction of toxicity in vivo. Toxicol In Vitro. 1992 Jul;6(4):295-302. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.